PTRS

Q: What is the price of Partners Bancorp (PTRS) today?

The current price of Partners Bancorp (PTRS) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Partners Bancorp (PTRS) pay dividends?

Partners Bancorp (PTRS) did not pay dividends over the past year.

Partners Bancorp

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

8.12

p/bv

0.90

DIVIDEND YIELD

2.32%

PTRS price

Partners Bancorp

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PTRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals PTRS

review the fundamentals of Partners Bancorp shares

P/E

8.12

Sector: -3.78 Industry: -3.78

P/S (PSR)

1.94

Sector: -4.21 Industry: -4.21

P/BV

0.90

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

2.32%

Sector: - Industry: -

ROA

1.03%

Sector: -65.35% Industry: -65.35%

ROE

11.07%

Sector: -65.97% Industry: -65.97%

ROIC

Sector: -2,913.96% Industry: -2,913.96%

NET MARGIN

23.92%

Sector: -40.35% Industry: -40.35%

GROSS MARGIN

73.53%

Sector: 36.77% Industry: 36.77%

OPERATING MARGIN

27.77%

Sector: -39.30% Industry: -39.30%

EV/EBITDA

4.97

Sector: -3.87 Industry: -3.87

EV/EBIT

4.97

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

0.08

Sector: 1.41 Industry: 1.41

BVPS

7.95

Sector: 1.88 Industry: 1.88

EPS

0.88

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.09

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.09

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

3.87%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

16.41%

Sector: - Industry: -

FAIR VALUE OF Partners Bancorp ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 0.00

Fair Value

$ 12.55

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PTRS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.50	6.87	25.92%	2.25%	$ 557.54 B	21.83%
PFE	19.79	1.64	8.29%	6.61%	$ 148.19 B	11.83%
ABBV	110.65	-60.83	-54.98%	2.97%	$ 402.20 B	5.79%
NVO	10.06	6.08	60.40%	4.34%	$ 190.87 B	37.15%
MRK	33.42	6.50	19.45%	2.75%	$ 298.59 B	13.59%
AZN	27.73	6.08	21.93%	1.72%	$ 288.04 B	17.19%
GILD	17.41	6.85	39.33%	2.47%	$ 160.42 B	30.99%
BMY	16.04	5.81	36.19%	4.37%	$ 116.72 B	15.01%
ZTS	12.68	10.37	81.75%	2.59%	$ 33.52 B	27.79%
REGN	14.94	2.10	14.08%	0.57%	$ 66.09 B	29.65%
HALO	24.20	38.43	158.82%	0.00%	$ 8.44 B	23.13%
AMGN	24.20	20.54	84.87%	2.80%	$ 188.77 B	20.96%
MCK	19.85	-113.34	-570.98%	0.41%	$ 94.53 B	1.18%
HRMY	12.82	2.05	16.00%	0.00%	$ 1.87 B	16.20%
VRTX	26.16	5.86	22.41%	0.00%	$ 113.49 B	35.51%
CAH	31.09	-18.09	-58.20%	0.99%	$ 48.34 B	0.62%
ADMA	11.37	4.82	42.37%	0.00%	$ 1.88 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PTRS Historical Dividends

current DY: 2.32%

5-year average DY: 1.93%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/16/2023	11/27/2023	0,08600000
Dividends	08/08/2023	08/17/2023	0,04000000
Dividends	05/08/2023	05/17/2023	0,04000000
Dividends	02/06/2023	02/15/2023	0,04000000
Dividends	11/07/2022	11/17/2022	0,04000000
Dividends	08/08/2022	08/19/2022	0,02500000
Dividends	05/09/2022	05/16/2022	0,02500000
Dividends	02/04/2022	02/15/2022	0,02500000
Dividends	12/20/2021	12/30/2021	0,02500000
Dividends	09/22/2021	10/01/2021	0,02500000
Dividends	06/22/2021	07/01/2021	0,02500000
Dividends	03/22/2021	04/01/2021	0,02500000
Dividends	12/22/2020	01/02/2021	0,02500000
Dividends	09/24/2020	10/05/2020	0,02500000
Dividends	06/24/2020	07/03/2020	0,02500000

ABOUT Partners Bancorp

Partners Bancorp

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

2020

Time since IPO - 6 years

220

Employees

Partners Bancorp (United States) is listed on the Nasdaq and has a market capitalization of $128.77 Millions, with shareholders equity totaling $143.14 Millions.

The company employs approximately 220 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Partners Bancorp reported $66.26 Millions in revenue, generating net income of $15.85 Millions.

Key financial metrics include a P/E ratio of 8.12, a price-to-book (P/B) ratio of 0.90, and a trailing twelve-month dividend yield of 2.32%.

The company trades under the ticker PTRS.

Market cap

$ 128.77 Millions

Net worth

$ 143.14 Millions

$ 143,143,635.00

Assets

$ 1.53 Billion

$ 1,533,033,525.00

Total Shares Outstanding

18.01 Millions

18,009,000

Average Daily Trading Volume

$ 11.17 Thousand

$ 11,173.16

Sector

Health Care

Industry

Biotechnology

PTRS

PTRS revenue and profits

Financial Results PTRS

DRAG THE FRAME TO SEE MORE DATA

PTRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.66 9,36% (12M)

P/E

19.85

0.41%

ROE

-570.98%

P/BV

-113.34

CAH - Cardinal Health

$ 205.71 34,82% (12M)

P/E

31.09

0.99%

ROE

-58.20%

P/BV

-18.09

JNJ - Johnson & Johnson

$ 232.77 55,23% (12M)

P/E

26.50

2.25%

ROE

25.92%

P/BV

6.87

MRK - Merck & Co.

$ 120.79 59,61% (12M)

P/E

33.42

2.75%

ROE

19.45%

P/BV

6.50

AZN - AstraZeneca

$ 185.95 29,58% (12M)

P/E

27.73

1.72%

ROE

21.93%

P/BV

6.08

ABBV - AbbVie

$ 227.23 23,51% (12M)

P/E

110.65

2.97%

ROE

-54.98%

P/BV

-60.83

NVO - Novo Nordisk

$ 42.96 --39,65% (12M)

P/E

10.06

4.34%

ROE

60.40%

P/BV

6.08

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.66 9,36% (12 M)

P/L

19.85

0.41%

ROE

-570.98%

P/VP

-113.34

CAH - Cardinal Health

$ 205.71 34,82% (12 M)

P/L

31.09

0.99%

ROE

-58.20%

P/VP

-18.09

JNJ - Johnson & Johnson

$ 232.77 55,23% (12 M)

P/L

26.50

2.25%

ROE

25.92%

P/VP

6.87

MRK - Merck & Co.

$ 120.79 59,61% (12 M)

P/L

33.42

2.75%

ROE

19.45%

P/VP

6.50

AZN - AstraZeneca

$ 185.95 29,58% (12 M)

P/L

27.73

1.72%

ROE

21.93%

P/VP

6.08

ABBV - AbbVie

$ 227.23 23,51% (12 M)

P/L

110.65

2.97%

ROE

-54.98%

P/VP

-60.83

NVO - Novo Nordisk

$ 42.96 --39,65% (12 M)

P/L

10.06

4.34%

ROE

60.40%

P/VP

6.08

Frequently Asked Questions

What is the price of Partners Bancorp (PTRS) today?

The current price of Partners Bancorp (PTRS) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Partners Bancorp (PTRS) pay dividends?

Partners Bancorp (PTRS) did not pay dividends over the past year.

Is Partners Bancorp (PTRS) a good investment?

Partners Bancorp (PTRS) is currently trading at $ 0.00 with a P/E ratio of 8.12. This represents a 976% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 2.32%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Partners Bancorp (PTRS) stock?

You can buy Partners Bancorp (PTRS) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PTRS and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Partners Bancorp (PTRS) yield today?

Over the past month, Partners Bancorp (PTRS) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 2.32%.

If you were to purchase 100 shares of Partners Bancorp (PTRS) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PTRS

Partners Bancorp

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PTRS

review the fundamentals of Partners Bancorp shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 2.32%

5-year average DY: 1.93%

type

Ex - Dividend Date

payment date

value

ABOUT Partners Bancorp

Partners Bancorp

United States

38 years

2020

220

PROFIT X PRICE PTRS

Financial Results PTRS

PTRS cash flow

Asset, Revenue and Profit Growth - PTRS

PTRS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions